Antibody Conjugation of a Chimeric BET Degrader Enables <i>in vivo</i> ActivityThomas H. Pillow, Peter S. Dragovich, Isabel Figueroa et al.|ChemMedChem|2019Cited by 193
Antibody-Mediated Delivery of Chimeric BRD4 Degraders. Part 2: Improvement of In Vitro Antiproliferation Activity and In Vivo Antitumor EfficacyPeter S. Dragovich, Xiaoyu Zhu, Thomas H. Pillow et al.|Journal of Medicinal Chemistry|2021Cited by 168
High-Content, High-Throughput Analysis of Cell Cycle Perturbations Induced by the HSP90 Inhibitor XL888Susan K. Lyman, Robert A. Blake|PLoS ONE|2011Cited by 35